Dietary methionine restriction with FOLFOX regimen as first line therapy of metastatic colorectal cancer: A feasibility study

Oncology

Volumn 78, Issue 3-4, 2010, Pages 205-209

  Durando, Xavier ^a   Farges, Marie Chantal ^b   Buc, Emmanuel ^c   Abrial, Catherine ^a   Petorin Lesens, Caroline ^c   Gillet, Brigitte ^c   Vasson, Marie Paule ^b   Pezet, Denis ^c   Chollet, Philippe ^a   Thivat, Emilie ^a  

^a CENTRE JEAN PERRIN   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

^c HÔTEL DIEU   (France)

Author keywords

Fluorouracil; FOLFOX; Leucovorin; Metastatic colorectal cancer; Methionine free diet; Oxaliplatine

Indexed keywords

FLUOROURACIL; FOLINIC ACID; METHIONINE; OXALIPLATIN;

ADULT; AGED; ANEMIA; ARTICLE; ASTHENIA; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; COLORECTAL CANCER; CONSTIPATION; DIARRHEA; DIET RESTRICTION; FEMALE; HUMAN; LEUKOPENIA; MALE; METASTASIS; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; NUTRITIONAL STATUS; PRIORITY JOURNAL; SENSORY NEUROPATHY; THROMBOCYTOPENIA; TREATMENT OUTCOME; VOMITING;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; DIET; DISEASE PROGRESSION; FEASIBILITY STUDIES; FEMALE; FLUOROURACIL; HUMANS; LEUCOVORIN; MALE; METHIONINE; MIDDLE AGED; MODELS, STATISTICAL; MONITORING, PHYSIOLOGIC; NEOPLASM METASTASIS; ORGANOPLATINUM COMPOUNDS; TREATMENT OUTCOME;

EID: 77951228206     PISSN: 00302414     EISSN: None     Source Type: Journal    
DOI: 10.1159/000313700     Document Type: Article

References (30)

1. Halpern BC, Clark BR, Hardy DN, Halpern RM, Smith RA: The effect of replacement of MET by homocystine on survival of malignant and normal adult mammalian cells in culture. Proc Natl Acad Sci USA 1974; 71: 1133-1136.
2. Stern PH, Hoffman RM: Enhanced in vitro selective toxicity of chemotherapeutic agents for human cancer cells based on a metabolic defect. J Natl Cancer Inst 1986; 76: 629-639.
3. Breillout F, Antoine E, Poupon MF: MET dependency of malignant tumors: a possible approach for therapy. J Natl Cancer Inst 1990; 82: 1628-1632.
4. Guo HY, Herrera H, Groce A, Hoffman RM: Expression of the biochemical defect of methionine dependence in fresh patient tumors in primary histoculture. Cancer Res 1993; 53: 2479-2483.
5. Hoffman RM: Altered methionine metabolism, DNA methylation and oncogene expression in carcinogenesis. A review and synthesis. Biochim Biophys Acta 1984; 738: 49-87.
6. Cellarier E, Durando X, Vasson MP, Farges MC, Demiden A, Maurizis JC, Madelmont JC, Chollet P: Methionine dependency and cancer treatment. Cancer Treat Rev 2003; 29: 489-499.
7. Guo H, Lishko VK, Herrera H, Groce A, Kubota T, Hoffman RM: Therapeutic tumor-specific cell cycle block induced by methionine starvation in vivo. Cancer Res 1993; 53: 5676-5679.
8. Poirson-Bichat F, Lopez R, Bras Goncalves RA, Miccoli L, Bourgeois Y, Demerseman P, Poisson M, Dutrillaux B, Poupon MF: Methionine deprivation and methionine analogs inhibit cell proliferation and growth of human xenografted gliomas. Life Sci 1997; 60: 919-931.
9. Kreis W, Goodenow M: Methionine requirement and replacement by homocysteine in tissue cultures of selected rodent and human malignant and normal cells. Cancer Res 1978; 38: 2259-2262.
10. Hoshiya Y, Kubota T, Inada T, Kitajima M, Hoffman RM: Methionine-depletion modulates the efficacy of 5-fluorouracil in human gastric cancer in nude mice. Anticancer Res 1997; 17: 4371-4375. (Pubitemid 28081714)
11. Goseki N, Endo M: Thiol depletion and chemosensitization on nimustine hydrochloride by methionine-depleting total parenteral nutrition. Tohoku J Exp Med 1990; 161: 227-239.
12. Yoshioka T, Wada T, Uchida N, Maki H, Yoshida H, Ide N, Kasai H, Hojo K, Shono K, Maekawa R, Yagi S, Hoffman RM, Sugita K: Anticancer efficacy in vivo and in vitro, synergy with 5-fluorouracil, and safety of recombinant methioninase. Cancer Res 1998; 58: 2583-2587.
13. Machover D, Zittoun J, Broet P, Metzger G, Orrico M, Goldschmidt E, Schilf A, Tonetti C, Tan Y, Delmas-Marsalet B, Luccioni C, Falissard B, Hoffman RM: Cytotoxic synergism of methioninase in combination with 5-fluorouracil and folinic acid. Biochem Pharmacol 2001; 61: 867-876.
14. Goseki N, Yamazaki S, Shimojyu K, Kando F, Maruyama M, Endo M, Koike M, Takahashi H: Synergistic effect of methioninedepleting total parenteral nutrition with 5-fluorouracil on human gastric cancer: a randomized, prospective clinical trial. Jpn J Cancer Res 1995; 86: 484-489.
15. Poirson-Bichat F, Goncalves RA, Miccoli L, Dutrillaux B, Poupon MF: Methionine depletion enhances the antitumoral efficacy of cytotoxic agents in drug-resistant human tumor xenografts. Clin Cancer Res 2000; 6: 643-653.
16. Tan Y, Sun X, Xu M, Tan X, Sasson A, Rashidi B, Han Q, Tan X, Wang X, An Z, Sun FX, Hoffman RM: Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice. Clin Cancer Res 1999; 5: 2157-2163.
17. Hoshiya Y, Kubota T, Matsuzaki SW, Kitajima M, Hoffman RM: Methionine starvation modulates the efficacy of cisplatin on human breast cancer in nude mice. Anticancer Res 1996; 16: 3515-3517. (Pubitemid 27085005)
18. Goldberg RM: Advances in the treatment of metastatic colorectal cancer. Oncologist 2005; 10: 40-48.
19. Minet-Quinard R, Van Praagh I, Kwiatkowski F, Beaujon G, Feillel V, Beaufrere B, Bargnoux PJ, Cynober L, Vasson MP: Preand postoperative aminoacidemia in breast cancer: a study vs. matched healthy subjects. Cancer Invest 2004; 22: 203-210.
20. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al: New guideline to evaluate the response to treatment in solid tumors. European Organisation for Research and Treatment of Cancer, National Cancer Institute of the United Stats, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92: 205-216.
21. Kwiatkowski F, Girard M, Hacene K, Berlie J: Sem: a suitable statistical software adaptated for research in oncology (in French). Bull Cancer 2000; 10: 715-721.
22. Lakshmanan FL, Perera WD, Scrimshaw NS, Young VR: Plasma and urinary amino acids and selected sulfur metabolites in young men fed a diet devoid of methionine and cystine. Am J Clin Nutr 1976; 29: 1367-1371.
23. Epner DE, Morrow S, Wilcox M, Houghton JL: Nutrient intake and nutritional indexes in adults with metastatic cancer on a phase I clinical trial of dietary methionine restriction. Nutr Cancer 2002; 42: 158-166.
24. Durando X, Thivat E, Farges MC, Cellarier E, D'Incan M, Demidem A,Vasson MP, Barthomeuf C, Chollet P: Optimal methioninefree diet duration for nitrosourea treatment: a phase I clinical trial. Nutr Cancer 2008; 60: 23-30.
25. Sun X, Yang Z, Li S, Tan Y, Zhang N, Wang X, Yagi S, Yoshioka T, Takimoto A, Mitsushima K, Suginaka A, Frenkel EP, Hoffman RM: In vivo efficacy of recombinant methioninase is enhanced by the combination of polyethylene glycol conjugation and pyridoxal 5-phosphate supplementation. Cancer Res 2003; 63: 8377-8383.
26. Yang Z, Wang J, Yoshioka T, Li B, Lu Q, Li S, Sun X, Tan Y, Yagi S, Frenkel EP, Hoffman RM: Pharmacokinetics, methionine depletion, and antigenicity of recombinant methioninase in primates. Clin Cancer Res 2004; 10: 2131-2138.
27. Yang Z, Sun X, Li S, Tan Y, Wang X, Zhang N, Yagi S, Takakura T, Kobayashi Y, Takimoto A, Yoshioka T, Suginaka A, Frenkel EP, Hoffman RM: Circulating half-life of PEGylated recombinant methioninase holoenzyme is highly dose dependent on cofactor pyridoxal-5-phosphate. Cancer Res 2004; 64: 5775-5778.
28. Yang Z, Wang J, Lu Q, Xu J, Kobayashi Y, Takakura T, Takimoto A, Yoshioka T, Lian C, Chen C, Zhang D, Zhang Y, Li S, Sun X, Tan Y, Yagi S, Frenkel EP, Hoffman RM: PEGylation confers greatly extended half-life and attenuated immunogenicity to recombinant methioninase in primates. Cancer Res 2004; 64: 6673-6678.
29. Tournigand C, Andre T, Achille E, Lledo G, Flesh M, Mery-Mignard D, Quinaux E, Couteau C, Buyse M, Ganem G, Landi B, Colin P, Louvet C, de Gramont A: FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 2004; 22: 229-237.
30. Leung FW: Etiologic factors of chronic constipation: review of the scientific evidence. Dig Dis Sci 2007; 52: 313-316.